Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
12/16/2010 | WO2007141796A3 Therapeutic uses of inhibitors of rtp801l |
12/16/2010 | US20100317724 Method for searching for homing endonucleases, their genes and their targets |
12/16/2010 | US20100317719 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field |
12/16/2010 | US20100317109 Factor |
12/16/2010 | US20100317105 Methods and compositions for controlling efficacy of RNA silencing |
12/16/2010 | US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9 |
12/16/2010 | US20100316703 Rna interference mediating small rna molecules |
12/16/2010 | US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
12/16/2010 | US20100316615 Antisense Oligonucleotides Against VR1 |
12/16/2010 | US20100316610 Mutant having uracil phosphoribosyl transferase activity |
12/16/2010 | US20100316609 Conditionally Replicating Viruses for Cancer Therapy |
12/16/2010 | DE102009024732A1 New oligonucleotide, comprising specified nucleotide sequences, is argonaute-1 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or tumors e.g. breast cancer |
12/16/2010 | DE102009024731A1 New oligonucleotide, comprising specified nucleotide sequences, is argonaute-2 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or tumors e.g. breast cancer |
12/16/2010 | DE102009024730A1 New oligonucleotide, comprising specified sequences, is argonaute-3a expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or microRNA-biogenesis |
12/16/2010 | DE102009024729A1 New oligonucleotide, comprising specified sequences, is argonaute-4 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or microRNA-biogenesis |
12/16/2010 | CA2764759A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection |
12/15/2010 | EP2261335A1 Compositions and methods for increasing bone mineralisation |
12/15/2010 | EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
12/15/2010 | EP2260863A1 Prophylactic/therapeutic agent for infectious disease |
12/15/2010 | EP2259787A2 Ikki inhibitor therapies and screening methods, and related ikki diagnostics |
12/15/2010 | EP1841878B1 Method for the generation of virus producing cell lines and cell lines |
12/15/2010 | EP1758998B1 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
12/15/2010 | EP1749098B1 Chimeric adenoviruses for use in cancer treatment |
12/15/2010 | EP1353942B1 Peptide inhibitors of hiv entry |
12/15/2010 | EP1001987B1 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
12/15/2010 | CN1665932B Vectors with modified protease-dependent tropism |
12/15/2010 | CN101918037A Methods and compositions for reducing skin damage |
12/15/2010 | CN101918036A Methods for inhibiting fascin |
12/15/2010 | CN101918035A Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent |
12/15/2010 | CN101918034A TAZ/WWTR1 for diagnosis and treatment of cancer |
12/15/2010 | CN101914564A Fusion of multiple enterotoxin genes of escherichia coli and application thereof |
12/15/2010 | CN101914541A Inhibitor for inhibiting expression of MBD2 and application thereof |
12/15/2010 | CN101914538A Deoxyribozyme for promoting tumor cell apoptosis |
12/15/2010 | CN101914536A Locked nucleic acid ribozyme of targeted serine-threonine protein kinase aurora kinase A and application thereof |
12/15/2010 | CN101914533A Interfering rna duplex having blunt-ends and 3'-modifications |
12/15/2010 | CN101914161A Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof |
12/15/2010 | CN101914145A Clostridium perfringens |
12/15/2010 | CN101914143A HIV-1 membrane fusion inhibitor and application thereof |
12/15/2010 | CN101912621A Method for preparing medicament for inhibiting porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus (PCV-2) |
12/15/2010 | CN101912620A Application of adenovirus mediated interleukin-24 for preparing radiotherapy hypersitization medicine |
12/15/2010 | CN101912619A Application of ING4 and IL-24 double-gene coexpression vector as radiotherapy sensitizing agent |
12/15/2010 | CN101912618A Preparation method of bone mesenchymal stem cell carrying NK4 gene and application thereof |
12/15/2010 | CN101912617A Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof |
12/15/2010 | CN101912605A Reinforced mosaic gene recombinant bacillus calmette-guerin and preparation method thereof |
12/15/2010 | CN101560500B Cell strain LaDR5 for secreting tumor necrosis factor receptor induced antibody |
12/15/2010 | CN101120099B Method of inhibiting expression of target mRNA using sirna consisting of nucleotide sequence complementary to said target mRNA |
12/15/2010 | CN101063129B Structure and usage of antisense oligonucleotide inhibiting ABHD2 gene expression |
12/14/2010 | USRE41996 Composition and methods for enhancing receptor-mediated cellular internalization |
12/14/2010 | US7851615 Lipophilic conjugated iRNA agents |
12/14/2010 | US7851596 Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides |
12/14/2010 | US7851592 Recombinant check point kinase for use in identifying modulator for use in treatment and prevention of cell proliferative disorders |
12/14/2010 | US7851454 Short immunomodulatory oligonucleotides |
12/14/2010 | US7851453 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
12/14/2010 | US7851447 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
12/14/2010 | US7851216 Binding nucleotide sequences; connecting gaps; drug mixture with carrier |
12/14/2010 | US7851214 Myxoviral vector as somatic gene therapeutic tool; genetic vaccines; tissue targeted therapy; antitumor agents |
12/14/2010 | US7851213 Expression vector comprising nucleotide sequences coding tumor antigens for use in development cancer vaccines; immunotherapeutics |
12/14/2010 | US7851212 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
12/14/2010 | US7850980 Chlamydia OMP antigen |
12/14/2010 | US7850976 Insulin resistance improving agents |
12/14/2010 | US7850971 PSMA antibodies and protein multimers |
12/14/2010 | US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders |
12/14/2010 | US7850963 Vascular endothelial growth factor 2 |
12/14/2010 | US7850960 Methods for regulation of stem cells |
12/14/2010 | US7850959 Methods and compositions for treating conditions involving abnormal angiogenesis |
12/14/2010 | US7850958 Recombinant double stranded RNA nucleocapsid and use of the same |
12/14/2010 | US7850957 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells |
12/14/2010 | US7850956 Immunization by inoculation of DNA transcription unit |
12/14/2010 | CA2285937C Modified proteins which bind extracellular matrix components |
12/14/2010 | CA2247989C C-c ckr-5,cc-chemokines receptor, derivatives thereof and their uses |
12/14/2010 | CA2233316C Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
12/14/2010 | CA2211427C Dna molecules, preparation thereof and use thereof in gene therapy |
12/09/2010 | WO2010141933A1 Specific inhibition of gene expression by nucleic acid containing a dicer substrate |
12/09/2010 | WO2010141842A2 Interlaced method for treating cancer or a precancerous condition |
12/09/2010 | WO2010141726A2 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
12/09/2010 | WO2010141724A2 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
12/09/2010 | WO2010141483A2 Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9 |
12/09/2010 | WO2010141471A2 Nucleic acid delivery compositions and methods of use thereof |
12/09/2010 | WO2010141135A2 Bacteriophages expressing antimicrobial peptides and uses thereof |
12/09/2010 | WO2010140834A2 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof |
12/09/2010 | WO2010140694A1 Method for screening of inhibitor using factor capable of enhancing production of amyloid-beta peptide, and inhibitor obtained by same |
12/09/2010 | WO2010139026A1 Therapeutic and diagnostic molecules |
12/09/2010 | WO2010120524A3 Methods of modulating an immune response to a viral infection |
12/09/2010 | US20100312525 Ribosome Structure and Protein Synthesis Inhibitors |
12/09/2010 | US20100311822 ACE2 Activation For Treatment Of Heart, Lung and Kidney Disease and Hypertension |
12/09/2010 | US20100311817 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences |
12/09/2010 | US20100311814 Modulation of stat5 expression |
12/09/2010 | US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
12/09/2010 | US20100311662 Treatment of Acute Coronary Syndrome with an Exendin |
12/09/2010 | US20100311189 Novel Receptor Nucleic Acids and Polypeptides |
12/09/2010 | US20100311161 Method for tissue regeneration |
12/09/2010 | US20100311145 Novel use of adenoviruses and nucleic acids that code for said viruses |
12/09/2010 | US20100311075 Human sodium-dependent bile acid transporter proteins |
12/09/2010 | US20100311045 Cancer |
12/09/2010 | US20100310601 Adeno-Associated Virus Materials and Methods |
12/09/2010 | US20100310593 Vaccines Against Chlamydia Infection |
12/09/2010 | US20100310516 Duplexed Parvovirus Vectors |
12/09/2010 | US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1 |
12/09/2010 | US20100310506 Immunoconjugates for the Treatment of Tumours |
12/09/2010 | CA2801178A1 Nucleic acid delivery compositions and methods of use thereof |